Secondary prevention strategy of cardiovascular disease using endothelial function testing

Circulation Journal

Volumn 79, Issue 4, 2015, Pages 685-694

  Matsuzawa, Yasushi ^a   Guddeti, Raviteja R ^a,b   Kwon, Taek Geun ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b MARSHFIELD CLINIC   (United States)

Author keywords

Coronary artery disease; Endothelial function; Secondary prevention

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; TORCETRAPIB;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL FUNCTION TEST; FUNCTION TEST; HEART FAILURE; HUMAN; IN-STENT RESTENOSIS; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MORTALITY; OUTCOME ASSESSMENT; REACTIVE HYPEREMIA PERIPHERAL ARTERIAL TONOMETRY; REVASCULARIZATION; REVIEW; SECONDARY PREVENTION; STENT THROMBOSIS; THORAX PAIN; TONOMETRY; VASODILATATION; BLOOD; METABOLISM; NURSING; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; THROMBOSIS; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; RISK FACTORS; THROMBOSIS;

EID: 84925641556     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0068     Document Type: Review

References (80)

1. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 2011; 58: 2432-2446.
2. Briffa TG, Hobbs MS, Tonkin A, Sanfilippo FM, Hickling S, Ridout SC, et al. Population trends of recurrent coronary heart disease event rates remain high. Circ Cardiovasc Qual Outcomes 2011; 4: 107-113.
3. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
4. Gössl M, Yoon MH, Choi BJ, Rihal C, Tilford JM, Reriani M, et al. Accelerated coronary plaque progression and endothelial dysfunction: Serial volumetric evaluation by IVUS. JACC Cardiovasc Imaging 2014; 7: 103-104.
5. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005; 111: 363-368.
6. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: The Cardiovascular Risk in Young Finns study. Circulation 2004; 110: 2918-2923.
7. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-372.
8. Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J, et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 1999; 274: 11924-11929.
9. Mayranpaa MI, Heikkila HM, Lindstedt KA, Walls AF, Kovanen PT. Desquamation of human coronary artery endothelium by human mast cell proteases: Implications for plaque erosion. Coron Artery Dis 2006; 17: 611-621.
10. Matsuzawa Y, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Konishi M, et al. Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol 2010; 55: 1688-1696.
11. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010; 56: 845-854.
12. Roura S, Bayes-Genis A. Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol 2009; 6: 590-598.
13. Polovina MM, Lip GY, Potpara TS. Endothelial (dys)function in lone atrial fibrillation. Curr Pharm Des 2014; 21: 622-645.
14. Mawatari K, Yoshioka E, Toda S, Yasui S, Furukawa H, Shimohata T, et al. Enhancement of endothelial function inhibits left atrial thrombi development in an animal model of spontaneous left atrial thrombosis. Circ J 2014; 78: 1980-1988.
15. Suzuki H, Matsuzawa Y, Konishi M, Akiyama E, Takano K, Nakayama N, et al. Utility of noninvasive endothelial function test for prediction of deep vein thrombosis after total hip or knee arthroplasty. Circ J 2014; 78: 1723-1732.
16. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.
17. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007; 49: 2379-2393.
18. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, et al. Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004; 44: 733-739.
19. Van der Heiden K, Gijsen FJ, Narracott A, Hsiao S, Halliday I, Gunn J, et al. The effects of stenting on shear stress: Relevance to endothelial injury and repair. Cardiovasc Res 2013; 99: 269-275.
20. Boilson BA, Kiernan TJ, Harbuzariu A, Nelson RE, Lerman A, Simari RD. Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med 2008; 5: 489-496.
21. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, et al. The assessment of endothelial function: From research into clinical practice. Circulation 2012; 126: 753-767.
22. Hwang HJ, Youn HJ, Lee MY, Park CS, Choi YS, Chung WB, et al. Change of coronary flow velocity during the cold pressor test is related to endothelial markers in subjects with chest pain and a normal coronary angiogram. Clin Cardiol 2012; 35: 119-124.
23. Lekakis J, Abraham P, Balbarini A, Blann A, Boulanger CM, Cockcroft J, et al. Methods for evaluating endothelial function: A position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil 2011; 18: 775-789.
24. Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Matsui T, et al. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease. Circ J 2006; 70: 49-56.
25. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
26. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44: 2137-2141.
27. Hamburg NM, Palmisano J, Larson MG, Sullivan LM, Lehman BT, Vasan RS, et al. Relation of brachial and digital measures of vascular function in the community: The Framingham heart study. Hypertension 2011; 57: 390-396.
28. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol (1985) 2006; 101: 545-548.
29. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996; 270: H1435-H1440.
30. Loscalzo J, Vita JA. Ischemia, hyperemia, exercise, and nitric oxide: Complex physiology and complex molecular adaptations. Circulation 1994; 90: 2556-2559.
31. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flowmediated dilation and cardiovascular event prediction: Does nitric oxide matter? Hypertension 2011; 57: 363-369.
32. Joannides R, Bellien J, Thuillez C. Clinical methods for the evaluation of endothelial function: A focus on resistance arteries. Fundam Clin Pharmacol 2006; 20: 311-320.
33. Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF Jr, et al. Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension 2004; 44: 134-139.
34. Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA, et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 2007; 27: 2113-2119.
35. Philpott AC, Lonn E, Title LM, Verma S, Buithieu J, Charbonneau F, et al. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol 2009; 103: 1610-1615.
36. Lind L, Berglund L, Larsson A, Sundstrom J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011; 123: 1545-1551.
37. Lavi S, Bae JH, Rihal CS, Prasad A, Barsness GW, Lennon RJ, et al. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart 2009; 95: 1525-1530.
38. Choi BJ, Prasad A, Gulati R, Best PJ, Lennon RJ, Barsness GW, et al. Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur Heart J 2013; 34: 2047-2054.
39. Choi BJ, Matsuo Y, Aoki T, Kwon TG, Prasad A, Gulati R, et al. Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis. Arterioscler Thromb Vasc Biol 2014; 34: 2473-2477.
40. Sawada T, Emoto T, Motoji Y, Hashimoto M, Kageyama H, Terashita D, et al. Possible association between non-invasive parameter of flow-mediated dilatation in brachial artery and whole coronary plaque vulnerability in patients with coronary artery disease. Int J Cardiol 2013; 166: 613-620.
41. Yoon MH, Reriani M, Mario G, Rihal C, Gulati R, Lennon R, et al. Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol 2013; 168: 1316-1321.
42. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92: 2426-2431.
43. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
44. Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, et al. Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. Circ Cardiovasc Interv 2013; 6: 452-459.
45. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D’Ambrosio A, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 2005; 111: 70-75.
46. Akcakoyun M, Kargin R, Tanalp AC, Pala S, Ozveren O, Akcay M, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: A prospective study. Coron Artery Dis 2008; 19: 337-343.
47. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954.
48. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658.
49. Targonski PV, Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 2003; 107: 2805-2809.
50. Xu Y, Arora RC, Hiebert BM, Lerner B, Szwajcer A, McDonald K, et al. Non-invasive endothelial function testing and the risk of adverse outcomes: A systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2014; 15: 736-746.
51. Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: A systematic review with metaanalysis. Int J Cardiol 2013; 168: 344-351.
52. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003; 42: 1037-1043.
53. Frick M, Suessenbacher A, Alber HF, Dichtl W, Ulmer H, Pachinger O, et al. Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol 2005; 46: 1006-1010.
54. Karatzis EN, Ikonomidis I, Vamvakou GD, Papaioannou TG, Protogerou AD, Andreadou I, et al. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol 2006; 98: 1424-1428.
55. Bosevski M, Borozanov V, Tosev S, Georgievska-Ismail L. Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease? Int J Cardiol 2009; 131: 290-292.
56. Corrado E, Camarda P, Coppola G, Muratori I, Ciaramitaro G, Farinella M, et al. Prognostic role of endothelial dysfunction and carotid intima-media thickness in patients undergoing coronary stent implantation. Int Angiol 2009; 28: 12-19.
57. Guazzi M, Reina G, Gripari P, Tumminello G, Vicenzi M, Arena R. Prognostic value of flow-mediated dilatation following myocardial infarction. Int J Cardiol 2009; 132: 45-50.
58. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53: 323-330.
59. Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail 2009; 11: 588-593.
60. Wang X, Guo F, Li G, Cao Y, Fu H. Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary intervention. Coron Artery Dis 2009; 20: 467-472.
61. Takishima I, Nakamura T, Hirano M, Kitta Y, Kobayashi T, Fujioka D, et al. Predictive value of serial assessment of endothelial function in chronic heart failure. Int J Cardiol 2012; 158: 417-422.
62. Careri G, Nerla R, Di Monaco A, Russo G, Stazi A, Villano A, et al. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes. Am J Cardiol 2013; 111: 51-57.
63. Matsue Y, Yoshida K, Nagahori W, Ohno M, Suzuki M, Matsumura A, et al. Peripheral microvascular dysfunction predicts residual risk in coronary artery disease patients on statin therapy. Atherosclerosis 2014; 232: 186-190.
64. Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc 2013; 2: e000426, doi:10.1161/JAHA.113.000426.
65. Nakamura T, Kitta Y, Uematsu M, Sugamata W, Hirano M, Fujioka D, et al. Ultrasound assessment of brachial endothelial vasomotor function in addition to carotid plaque echolucency for predicting cardiovascular events in patients with coronary artery disease. Int J Cardiol 2013; 167: 555-560.
66. Watanabe S, Amiya E, Watanabe M, Takata M, Ozeki A, Watanabe A, et al. Simultaneous heart rate variability monitoring enhances the predictive value of flow-mediated dilation in ischemic heart disease. Circ J 2013; 77: 1018-1025.
67. Ikonomidis I, Kadoglou NN, Tritakis V, Paraskevaidis I, Dimas K, Trivilou P, et al. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease. Atherosclerosis 2014; 234: 34-41.
68. Mei WY, Liao LZ, Hu X, Zhai YS, Du ZM, Luo CF. Combined PAPPA-A and brachial flow-mediated dilatation to predict outcomes of patients with non-ST-elevation MI. Exp Clin Cardiol 2014; 20: 3735-3754.
69. Hasin T, Matsuzawa Y, Guddeti RR, Aoki T, Kwon TG, Schettle S, et al. Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events. Circ J 2015; 79: 770-777.
70. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31: 1142-1148.
71. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.
72. Little WC, Downes TR, Applegate RJ. The underlying coronary lesion in myocardial infarction: Implications for coronary angiography. Clin Cardiol 1991; 14: 868-874.
73. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
74. Matsuzawa Y, Lerman A. Endothelial dysfunction and coronary artery disease: Assessment, prognosis, and treatment. Coron Artery Dis 2014; 25: 713-724.
75. Matsuzawa Y, Guddeti RR, Kwon TG, Lerman LO, Lerman A. Treating coronary disease and the impact of endothelial dysfunction. Prog Cardiovasc Dis 2014 October 22, doi:10.1016/j.pcad.2014.10.004.
76. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357: 2109-2122.
77. Simic B, Hermann M, Shaw SG, Bigler L, Stalder U, Dorries C, et al. Torcetrapib impairs endothelial function in hypertension. Eur Heart J 2012; 33: 1615-1624.
78. Kannel WB. Overview of atherosclerosis. Clin Ther 1998; 20(Suppl B): B2-B17.
79. Goff DC Jr, Lloyd-Jones DM, Bennett G, O’Donnell CJ, Coady S, Robinson J, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2935-2959.
80. Yamashina A. Guidelines for non-invasive vascular function test (JCS 2013) (in Japanese). http://www.j-circ.or.jp/guideline/index.htm (accessed December 10, 2014).